CLINICAL_TRIALS
research
· 2016-08-30
Clinical Trial Update: Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia [Phase 4]
Summary
This document reports a Phase 4 clinical trial evaluating nicotinic acid for managing hyperphosphatemia in patients undergoing hemodialysis; the current trial s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiujiang No.1 People's Hospital | Conditions: Hyperphosphatemia | Phase 4 | Status: UNKNOWN